研究
2019 研究業績・論文発表
論文
T. Fujino, Y. Kobayashi, K. Suda, T. Koga, M. Nishino, S. Ohara, M. Chiba, M. Shimoji, K. Tomizawa, T. Takemoto and T. Mitsudomi
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro
J Thorac Oncol (2019) 14: 1753-1765.
Y. Kobayashi and T. Mitsudomi
Ground glass nodules with 5 years' stability can grow after 10-year follow-up: do genetic features determine the fate?
Transl Lung Cancer Res (2019) 8: S425-S427.
T. Mitsudomi
BRAF Fusion - Another Mechanism of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
J Thorac Oncol (2019) 14: 764-765.
M. Nishio, K. Nakagawa, T. Mitsudomi, N. Yamamoto, T. Tanaka, H. Kuriki, A. Zeaiter and T. Tamura
Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40]
Lung Cancer (2019) 132: 160.
S. Ohara, K. Tomizawa, S. Shimizu, K. Suda, T. Fujino, A. Hamada, T. Koga, M. Nishino, Y. Kobayashi, K. Sato, M. Chiba, M. Shimoji, T. Takemoto, J. Soh and T. Mitsudomi
Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis
Surg Case Rep (2019) 5: 105.
K. Suda, M. Shimoji, S. Shimizu, K. Sato, M. Chiba, K. Tomizawa, T. Takemoto, J. Soh and T. Mitsudomi
Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas
Biomolecules (2019) 9:
K. Tomizawa, K. Sato, S. Ohara, T. Fujino, T. Koga, M. Nishino, Y. Kobayashi, M. Chiba, M. Shimoji, K. Suda, T. Takemoto and T. Mitsudomi
Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis
Surg Today (2019) 49: 513-520.